<DOC>
	<DOCNO>NCT01445626</DOCNO>
	<brief_summary>This study use retrospective data evaluate efficacy , safety , re-injection interval OZURDEX速 treatment macular oedema due Retinal Vein Occlusion ( RVO ) .</brief_summary>
	<brief_title>A Retrospective Data Collection Study Patients Receiving Dexamethasone Intravitreal Implant ( Ozurdex速 ) Macular Oedema Due Retinal Vein Occlusion ( RVO )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Macular oedema study eye due BRVO CRVO Received least 2 OZURDEX速 injection study eye Received OZURDEX速 injection part clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>